Blood-based biomarkers of Alzheimer's disease: challenging but feasible - Test2 - elhamkhani - TriplyDB

Blood-based biomarkers of Alzheimer's disease: challenging but feasible

Blood-based biomarkers of Alzheimer's disease: challenging but feasible

http://www.wikidata.org/entity/Q33824444

about

Targeting innate immunity for neurodegenerative disorders of the central nervous system Update on Biomarkers for the Detection of Endometriosis The potential of pathological protein fragmentation in blood-based biomarker development for dementia - with emphasis on Alzheimer's disease Biomarkers in Alzheimer's disease analysis by mass spectrometry-based proteomics Exploring Biomarkers for Alzheimer's Disease Exploring the potential of the platelet membrane proteome as a source of peripheral biomarkers for Alzheimer's disease.Dietary methanol regulates human gene activity The future of blood-based biomarkers for Alzheimer's disease.Biomarkers of Alzheimer's disease risk in peripheral tissues; focus on buccal cells.Developing novel blood-based biomarkers for Alzheimer's disease Identifying and validating biomarkers for Alzheimer's disease.Blood biomarkers for Alzheimer's disease.Altered cytological parameters in buccal cells from individuals with mild cognitive impairment and Alzheimer's disease.Follow-up plasma apolipoprotein E levels in the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing (AIBL) cohort.Using biomarkers to improve detection of Alzheimer's disease.Central Nervous System and Peripheral Inflammatory Processes in Alzheimer's Disease: Biomarker Profiling Approach.Will posttranslational modifications of brain proteins provide novel serological markers for dementias?Alzheimer's disease biomarker discovery using in silico literature mining and clinical validation.Development of a standardized flow cytometric method to conduct longitudinal analyses of intracellular CD3ζ expression in patients with head and neck cancer.Plasma proteomics for the identification of Alzheimer disease.Blood metabolite markers of cognitive performance and brain function in aging.Blood metabolite markers of preclinical Alzheimer's disease in two longitudinally followed cohorts of older individuals.Association of plasma and cortical amyloid beta is modulated by APOE ε4 status European multicentre double-blind placebo-controlled trial of Nilvadipine in mild-to-moderate Alzheimer's disease-the substudy protocols: NILVAD frailty; NILVAD blood and genetic biomarkers; NILVAD cerebrospinal fluid biomarkers; NILVAD cerebral blo Serum-based protein profiles of Alzheimer's disease and mild cognitive impairment in elderly Hispanics.Plasma phospholipids identify antecedent memory impairment in older adults.Neurodegeneration, β-amyloid and mood disorders: state of the art and future perspectives.Review: systemic inflammation and Alzheimer's disease.Progress towards a consensus on biomarkers for Alzheimer's disease: a review of peripheral analytes.Risk factors for the progression of mild cognitive impairment to dementia.Biomarker-driven therapeutic management of Alzheimer's disease: establishing the foundations.Amyloid-beta and depression in healthy older adults: a systematic review.Potential peripheral biomarkers for the diagnosis of Alzheimer's disease.Metabolomic-guided discovery of Alzheimer's disease biomarkers from body fluid.PiB-PET Imaging-Based Serum Proteome Profiles Predict Mild Cognitive Impairment and Alzheimer's Disease.Dynamic changes of oligomeric amyloid β levels in plasma induced by spiked synthetic Aβ42 Evidence for acute neurotoxicity after chemotherapy.Korean Brain Aging Study for the Early Diagnosis and Prediction of Alzheimer's Disease: Methodology and Baseline Sample Characteristics.Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study.Glucose-6-phosphate dehydrogenase a novel hope on a blood-based diagnosis of Alzheimer's disease.

P2860

Q26744219-83F9A3BC-D9C7-46D8-B7DD-01BE591D6FA5 Q26799195-53F6E15B-89EE-4EBD-B6AB-678AB604A1F0 Q26853347-F9D0750A-D24A-4F69-82ED-E6B0E270C5E7 Q27024518-97851278-A650-4981-A818-4FEE68260DA7 Q28079218-52FEC5C7-68E4-4E87-A7E3-0DD4C1F58F14 Q33745920-B2EC05FF-5A95-416E-93BE-8B7C7E0B098C Q33916628-98CF768B-9D89-4E01-A2C9-FF7002C7DADF Q34026317-B5279188-E518-4093-B628-B9C3A8C2F54F Q34201730-D3F60C98-E8C5-4AEA-85F6-3A9C33D21F90 Q34394080-05B09C8C-71E8-4026-BE0E-4FA9E979F60E Q34468961-C052A340-6911-48BD-877C-8F5E53F13455 Q34624763-B24C29EB-F5CE-422D-BFA7-64BCB8F2600A Q35116978-97FEC72D-1809-455D-95F9-9931B31FED9B Q35342893-6BFBCE60-2C27-4988-8370-08E1E5CA9B12 Q35533115-7D651840-920F-450B-841A-C08A16B4E645 Q35990600-02281023-D9B9-4AA2-A3A6-A2863077D09D Q36072517-CC7C6158-57EC-458C-84F8-83D081854C0C Q36430448-AC3A019E-C7F9-4161-955F-516DE836F096 Q36640727-DAC6935A-56DC-407F-A406-9A8B4DE254EB Q36767124-6E773423-474D-4FBE-8867-C30FE3757B20 Q37057711-7F283232-C446-4B36-A9DE-F1F72E634DF3 Q37100094-0646090B-12B1-4A3D-82AB-728F56F2E56B Q37112462-448F8F30-10CD-45DE-9531-C6B749B7C94F Q37133760-2AEB7B84-F595-4F4A-AEA8-247D3F4D8FF0 Q37342809-30F275F3-9600-493B-9373-139C952F01A2 Q37714213-C1EDF2F9-D0C9-473E-9808-5CB00E291527 Q38045223-68D7321C-4B62-46B9-911F-F8327215B21F Q38050498-2F70DA77-9F31-4516-ABF1-49DE871964EF Q38125769-5646BFCC-4367-4CD3-9E2F-C4251DAF5721 Q38149355-4CB9C28E-E401-4951-9EB2-0752A1EDD902 Q38150708-D6FE6771-5D14-452E-B09C-6BC1CA947BB9 Q38270148-3F128845-1793-4EA3-A7E5-0B73C6078F6A Q38833738-9540F228-87AE-452A-8DFA-CDAA4B3BB5F5 Q39181900-C10068E0-6B20-4A67-B77F-E5F0C64F687D Q39620255-6C48FBF5-E230-46BF-9CF7-FEA3C4BC3A5F Q42682593-8557CA25-5CB4-4C00-86F0-45588C70FEFD Q42769499-872E3570-C0D0-4927-ABB2-59342880B1FB Q47141112-58E48982-7FB3-4FFA-9A17-31AEFE1E7180 Q47549112-1308CDD8-C0FB-42FC-B401-B775EA9FD318 Q47614451-E0604775-6738-4AB1-B32F-42AF4B28759E

P2860

Blood-based biomarkers of Alzheimer's disease: challenging but feasible

http://www.wikidata.org/entity/Q33824444

description

2010 nî lūn-bûn

@nan

2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Blood-based biomarkers of Alzheimer's disease: challenging but feasible

@ast

Blood-based biomarkers of Alzheimer's disease: challenging but feasible

@en

type

label

Blood-based biomarkers of Alzheimer's disease: challenging but feasible

@ast

Blood-based biomarkers of Alzheimer's disease: challenging but feasible

@en

prefLabel

Blood-based biomarkers of Alzheimer's disease: challenging but feasible

@ast

Blood-based biomarkers of Alzheimer's disease: challenging but feasible

@en

P1433

Q33824444-8CCB3B18-997E-4DB0-840D-DFDB38476E06

P1476

Q33824444-69521C0E-B3F9-4C9D-99E0-3B53FDA2BA45

P2860

Q33824444-03FD2F08-A409-4A73-BB1D-80E2225EF4F4

Q33824444-07BA8A36-54B0-4F93-9618-63FC50B90FD2

Q33824444-0A6920A7-71A8-4717-88A4-901A029D2413

Q33824444-0D633008-2383-4AA0-B932-A5D2A27A1F06

Q33824444-0E088240-A3AF-45FE-A596-A7DEEF0BBE1D

Q33824444-0F2D04A8-2A2D-4759-AC32-5021DFC0031A

Q33824444-11155F7B-BED6-419C-AF62-62BC19B09ED9

Q33824444-188FEFB4-62DA-4AA3-9432-F80FADEC465C

Q33824444-1C98B421-0118-4542-A63B-6DDE41FDF2A7

Q33824444-2115021A-BF38-4B0A-88C4-075DB64243D3

P304

Q33824444-12017ACB-9BF0-45A9-BB68-CBB9E1FA0323

P31

Q33824444-2DC5DAAE-314F-4963-A792-4B7D3BCBDC96

P356

Q33824444-446127D5-6450-46DB-98FF-D6CBCDEF0C45

P433

Q33824444-6441EEFA-1312-47CC-B058-0F06D0C779C3

P478

Q33824444-785D6C6E-7986-4C3D-900B-68CF5D9166CB

P50

Q33824444-1BF13671-ECD2-425E-A9C3-03BF6344A6B5

Q33824444-4F28D51A-82D0-43B3-9730-52148EF3EDD0

P577

Q33824444-914354D9-20F6-44D8-80AD-370EC1F02BF2

P5875

Q33824444-AC3574ED-ABFB-45CC-A17B-3E1728EB4264

P698

Q33824444-2417392E-27FB-4A5B-A90E-FB0ACE83E5EE

P921

Q33824444-B78C2557-21AE-4B9D-BC27-159CE0E28CBD

Q33824444-FFC3AFCA-AF25-4017-BFE6-1FD2C3F29D2F

P932

Q33824444-AC5A414E-2E5D-469C-84AF-596972FE351A

P356

P1433

Biomarkers in Medicine

P1476

Blood-based biomarkers of Alzheimer's disease: challenging but feasible

@en

P2860

Detection of microRNA expression in human peripheral blood microvesicles

MicroRNA: Implications for Alzheimer Disease and other Human CNS Disorders

Homocysteine and folate as risk factors for dementia and Alzheimer disease

Identification of a 5-protein biomarker molecular signature for predicting Alzheimer's disease

Alzheimer's disease: the amyloid cascade hypothesis

Analysis of potential transcriptomic biomarkers for Huntington's disease in peripheral blood.

The dynamic range of protein expression: a challenge for proteomic research.

MicroRNA expression in Alzheimer blood mononuclear cells

The Alzheimer's disease neuroimaging initiative.

Challenges in deriving high-confidence protein identifications from data gathered by a HUPO plasma proteome collaborative study.

P304

65-79

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/BMM.09.84

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

Simon Lovestone

Madhav Thambisetty

P577

2010-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

43132390

http://www.w3.org/2001/XMLSchema#string

P698

20387303

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

2863057

http://www.w3.org/2001/XMLSchema#string